-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Coya Therapeutics, Inc. quarterly and annual Depreciation history and change rate from 2021 to Q3 2025.
- Coya Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2025 was $6,840, a 0.02% decline year-over-year.
- Coya Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $27,360, a 0% decline year-over-year.
- Coya Therapeutics, Inc. annual Depreciation for 2024 was $27,361, unchanged from 2023.
- Coya Therapeutics, Inc. annual Depreciation for 2023 was $27,361, unchanged from 2022.
- Coya Therapeutics, Inc. annual Depreciation for 2022 was $27,361, a 69.6% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)